Cargando…
Hyaluronic acid-coated chitosan nanoparticles as targeted-carrier of tamoxifen against MCF7 and TMX-resistant MCF7 cells
Tamoxifen (TMX) is used to treat hormone-receptor-positive breast cancers at early stages. This research aimed to assess the potential of NPs in targeted delivery of TMX against MCF7 and TMX-resistant MCF7 breast cancer cell lines. For this purpose, a targeted delivery system including chitosan NPs...
Autores principales: | Nokhodi, Fariba, Nekoei, Mehdi, Goodarzi, Mohammad Taghi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8843906/ https://www.ncbi.nlm.nih.gov/pubmed/35157166 http://dx.doi.org/10.1007/s10856-022-06647-6 |
Ejemplares similares
-
In vitro targeting and selective killing of mcf-7 and colo320dm cells by 5-fluorouracil anchored to carboxylated SWCNTs and MWCNTs
por: Kamble, Rutuja V., et al.
Publicado: (2021) -
Targeted delivery of a short antimicrobial peptide (CM11) against Helicobacter pylori gastric infection using concanavalin A-coated chitosan nanoparticles
por: Moosazadeh Moghaddam, Mehrdad, et al.
Publicado: (2023) -
The ascension of nanosponges as a drug delivery carrier: preparation, characterization, and applications
por: Tiwari, Kartik, et al.
Publicado: (2022) -
Tumor-microenvironment responsive nano-carrier system for therapy of prostate cancer
por: Li, Lujing, et al.
Publicado: (2023) -
Magnetite graphene oxide-albumin conjugate: carrier for the imatinib anticancer drug
por: Mashreghi, Maral, et al.
Publicado: (2023)